OMRON Healthcare Co., Ltd., a global leader in home health monitoring devices, has announced its support for May Measurement Month 2026, an annual blood pressure screening and awareness campaign held in conjunction with World Hypertension Day on May 17. The company will donate approximately 3,000 blood pressure monitors to participating countries, including models capable of detecting the possibility of atrial fibrillation (AFib), a common but often undiagnosed arrhythmia that increases the risk of stroke and heart failure.
Hypertension remains the leading risk factor for cardiovascular disease globally, contributing to over 10 million deaths each year. Despite the availability of effective management strategies, awareness and treatment rates remain suboptimal in many regions. Launched in 2017, May Measurement Month aims to address this gap by promoting regular blood pressure monitoring. To date, the campaign has screened more than 7 million people worldwide, identifying over 1 million individuals with previously untreated hypertension.
OMRON Healthcare has been a supporter of May Measurement Month since its inception, contributing to screening activities in approximately 120 countries and regions. With the latest donation, the company has provided around 33,000 blood pressure monitors to the campaign over the years. This year's donation includes AFib-capable models, which can help detect a condition that often goes undiagnosed despite being a major risk factor for stroke and heart failure. The May–July campaign will feature screening events, educational activities, and guidance on lifestyle changes for hypertension management.
Professor Neil R. Poulter, Chief Investigator and Chair of Trustees of May Measurement Month, emphasized the importance of the initiative. "Hypertension (high blood pressure) is the leading risk factor for cardiovascular diseases, including stroke, heart attacks, heart failure, and the potentially life-threatening arrhythmia atrial fibrillation. Furthermore, it is increasingly clear that regular home blood pressure monitoring improves hypertension management, which in turn reduces these major adverse cardiovascular events and the risk of atrial fibrillation. By donating blood pressure monitors that are also capable of detecting probable atrial fibrillation, this initiative can enhance early detection and treatment of hypertension and atrial fibrillation, ultimately helping to save more lives around the world from cardiovascular diseases."
Ayumu Okada, President and CEO of OMRON Healthcare Co., Ltd., highlighted the alignment of the campaign with the company's vision. "Since the launch of our first home blood pressure monitor in 1973, we have worked alongside healthcare professionals to promote the importance of blood pressure monitoring and improve access to home measurement. The goals of May Measurement Month align closely with our own Going for ZERO vision, which aims to eliminate cerebro-cardiovascular events worldwide, and we will continue to collaborate with May Measurement Month to improve global cardiovascular health outcomes through the further expansion of this important initiative."
For more information about May Measurement Month, visit https://maymeasure.org. OMRON Healthcare's commitment to cardiovascular health is part of its broader mission to reduce cerebro-cardiovascular events through innovative home monitoring solutions and digital health ecosystems that connect patients with healthcare professionals. With over 400 million units sold globally, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals, operating in over 130 countries.
